Articles tagged with Eye Diseases
A deep learning tool has been developed to reliably diagnose moon blindness in horses based on photos, with a high accuracy rate of 93%. The tool supports veterinary doctors in making diagnoses, particularly valuable for less experienced professionals or horse owners in regions with limited vets.
Researchers have identified CAR-T cell therapy as a potential treatment for autoimmune diseases such as rheumatoid arthritis, SLE, and type 1 Diabetes Mellitus. Early studies have shown promising results in reducing disease activity and improving patients' quality of life, but long-term data on safety and efficacy is limited.
A study led by the University of Cambridge found that AI models like GPT-4 outperformed doctors in diagnosing and treating eye problems. The researchers suggest using AI for triaging patients and providing advice in well-controlled contexts, where access to specialist healthcare professionals is limited.
Researchers at the University of Pittsburgh have discovered how to overcome resistance to conventional immunotherapies in metastatic uveal melanoma. They developed a clinical tool called Uveal Melanoma Immunogenic Score (UMIS) to predict patient response and improve treatment outcomes.
Researchers at NIH developed a novel AI-based method called P-GAN to improve next-generation imaging of cells in the retina. The technique reduces imaging acquisition and processing time by 100-fold, yielding greater contrast and improving image quality.
A groundbreaking study reveals that targeting cholesterol metabolism can mitigate Zika virus-induced ocular pathology, offering promising therapeutic strategies. Researchers identified ABCG1 and SREBP-2 as key players in the pathway, and treatments with LXR agonists or SREBP-2 inhibitors showed promise in animal models.
The study found that Streptococcus and Pedobacter bacteria species were present in healthy eyes, while more Acinetobacter species were found in dry eye samples. This knowledge could lead to improved treatments for various eye problems and diseases affecting the gut microbiome.
Researchers at Purdue University are developing patent-pending smart soft contact lenses that can continuously monitor or treat chronic ocular diseases like glaucoma, corneal neovascularization and dry eye syndromes. The $6.7 million funding from the National Eye Institute will be used to refine the lenses and conduct clinical trials.
Researchers at the University of Alabama at Birmingham discovered that the ALG6 variant is associated with altered phenotypes in patients with RP59, including delayed peripheral rod degeneration and diminished macular cone photoreceptor health. This study highlights the complex effects of modifier genes in human genetic disease.
A novel approach estimates metabolic activity and infers blood glucose levels from near-infrared measurements in commercial smartphones and smartwatches. The phase delay between oxyhemoglobin and deoxyhemoglobin signals closely relates to oxygen consumption during cardiac cycles, serving as a gauge for metabolism.
Children with amblyopia are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood. The study found a correlation between amblyopia and increased risk of heart attack, even when other risk factors were taken into account.
A new study finds that gut bacteria can cause blindness in some inherited eye diseases by breaching the body's defenses. Treating these bacteria with antimicrobials may prevent sight loss, offering a potential new approach to treatment.
A recent UCI study found profound similarities between humans and insects in producing the critical light-absorbing molecule of the retina, 11-cis-retinal. The research provides new insights into retinal disease origins and potential therapeutic targets, with implications for understanding loss-of-function mutations in RPE65.
The study reveals a significant prevalence of refractive error in African American adults, affecting their quality of life and work productivity. Providing universal vision care coverage can reduce this burden by over two-thirds, improving lives and increasing economic opportunities.
A new study published in JAMA Ophthalmology suggests that artificial intelligence can match or exceed the expertise of seasoned ophthalmic specialists in diagnosing and treating patients with glaucoma and retina disorders. The AI system, GPT-4, demonstrated superior performance in response to glaucoma questions and case-management advice.
Researchers have discovered a previously unknown mechanism behind immune tolerance, where B cells teach T cells to ignore the body's own proteins. This failure can lead to autoimmune diseases such as Multiple Sclerosis-like Neuromyelitis optica.
A study published in Nature Communications has identified key genes, biological processes, and cell types that may contribute to the development of primary open-angle glaucoma. The research highlights potential mechanisms involving gene expression, cellular regulation, and vascular development.
Researchers developed a compact, cost-effective PA sensing instrument for biomedical tissue diagnosis, showcasing its potential to streamline sampling processes and improve diagnostic accuracy for breast disease. The instrument successfully differentiated various tissue types based on quantitative spectral parameters.
University of Melbourne researchers have received a $35 million grant to develop a world-first tissue engineered cornea to treat corneal blindness. The technology has the potential to provide corneal tissue to surgeons worldwide, including countries with limited eye banks.
Researchers have discovered a key enzyme that stops cancer cell death and found it plays a pro-survival function in cancer cells. This finding provides crucial information for developing new cancer-fighting strategies.
Researchers used fMRI to assess brain responses to lights stimulating only cone cells in dogs with different types of retinal diseases. The study found that gene augmentation therapy restored response in cortex to black and white stimulation, making this disease a promising one for photoreceptor cell replacement treatment.
Researchers studied how epithelial cells sense small changes in their environment using ion channels. They found that even small movements can trigger rapid intracellular calcium changes via mechanosensitive cation channels, which play a key role in touch sensation and other physiological functions.
A study combines retinal imaging, genetics, and big data to estimate the likelihood of developing eye and systemic diseases. The researchers identified significant associations between retinal layer thickness and increased risk of various diseases, including ocular, neuropsychiatric, cardiac, metabolic, and pulmonary diseases.
Researchers found that 94% of patients with posterior cortical atrophy had Alzheimer's pathology, while only 70% of those with memory loss did. Early identification of PCA may lead to better treatment options for Alzheimer's patients.
A recent study has identified two novel gene variants linked to primary open-angle glaucoma (POAG) in individuals of African descent. The analysis of 11,275 individuals revealed that these variants are more common in people of African ancestry and contribute to the disease's pathophysiology.
A new analysis focusing on people of African ancestry identified three gene variants linked to glaucoma, including two likely causal variants and one associated with cup-to-disc ratio. The study's findings could enhance early screening and personalized therapeutic interventions for this population.
A new type of contact lens has been developed to diagnose glaucoma by monitoring eye pressure, providing a more accurate diagnosis and easier treatment. The lenses contain micro-sensors that track changes in intraocular pressure over several hours, sending the data wirelessly for analysis by an ophthalmologist.
A new study published in Nature Communications found that AI-driven eye exams can close care gaps among racial and ethnic minority youth with diabetes, populations with historically higher rates of diabetic retinopathy. The technology uses cameras to take pictures of the back of the eye without dilation and provides immediate results.
A pioneering study published in The American Journal of Pathology reveals the cytoprotective and proregenerative effects of neuropeptide α-MSH in promoting corneal healing after eye injury. The treatment has shown impressive therapeutic potential in reducing the need for corneal transplants.
Researchers identified Elovanoid-34, a molecule that modulates the activity of TXNRD1 protein, which regulates antioxidant defenses. This discovery opens new therapeutic avenues for degenerative brain and eye diseases, as well as promoting healthy aging.
Researchers used AI to analyze electroretinogram signals from children's eyes, identifying unique features associated with autism spectrum disorder (ASD). The test, completed within 10 minutes, shows promise for diagnosing ASD more accurately and efficiently than current methods.
Researchers develop a versatile imaging system for targeted spectroscopy in the eye fundus, allowing for continuous color imaging and spectral measurements. The system enables users to select targets and move them to any location within the eye fundus region without realignment or fixation changes.
Researchers at NIH mapped the 3D organization of genetic material in human retinal formation, revealing a dynamic process that regulates gene expression. The findings lay a foundation for understanding clinical traits in many eye diseases.
Researchers discovered that Nectandrin B, a bioactive lignan compound from nutmeg, extends the lifespan of Drosophila melanogaster by as much as 42.6%. The study found that Nectandrin B reduces intracellular ROS levels and improves age-related symptoms such as locomotive deterioration and neurodegeneration.
Scientists at Johns Hopkins Medicine have identified a molecular pathway involving oxidative stress and the protein HIF-1 that contributes to both wet and dry age-related macular degeneration. Researchers found that while HIF-1 promotes blood vessel growth in retinal cells, it also protects against cell death in advanced dry AMD.
A novel study has implicated granulocyte colony-stimulating factor (G-CSF) in both bronchopulmonary dysplasia and retinopathy of prematurity, making it a promising therapeutic candidate. G-CSF deficiency was shown to protect against these diseases, suggesting wide-ranging protection.
A study of over 50,000 Korean adolescents found that those using smartphones for more than 4 hours a day had higher rates of stress, thoughts of suicide, and substance use. In contrast, lighter users showed no greater health risks compared to non-users.
Researchers have developed a light-activatable prodrug nanomedicine that combines anti-angiogenic and photodynamic therapy to treat wet AMD. The treatment is minimally invasive and shows excellent therapeutic efficacy without side effects.
Researchers have successfully converted human retinal cells, specifically Muller glia, into neurons in a lab setting using an artificial fish-like genetic program. This breakthrough could potentially serve as a new source of neurons to treat vision loss caused by disease or trauma.
A multidisciplinary team at Mass Eye and Ear has identified a promising new strategy for glaucoma cell replacement therapy by guiding stem cells to the retina. The researchers created RGCs out of stem cells and used chemokines to guide them to their correct positions within the retina.
Researchers Reshmi Parameswaran and Carlos Subauste at Case Western Reserve University have received funding for their work on finding new treatments for B-cell cancer and diabetic retinopathy, a leading cause of blindness. They aim to develop more effective cell therapies and inhibitors to treat these diseases.
Researchers at the University of Arizona College of Medicine – Tucson used stem cell technology to improve research models for Parkinson’s disease, uncovering clues that may help scientists detect the condition earlier and develop better treatments.
Researchers at Nagoya University identified the link between iron and blindness caused by ocular toxoplasmosis, a parasite affecting one-third of the world's population. Controlling iron levels has shown promise as a potential cure.
A new study by Anglia Ruskin University and University of Oxford highlights the lack of clinical research on severe sight impairment (SSI) among working-age individuals in the UK. The study finds that inherited retinal disorders, such as IRDs, are under-researched despite being a leading cause of SSI certifications in this population.
A new international clinical trial found that a drug candidate is highly effective in treating Acanthamoeba keratitis with medical cure rates of 87%, reducing the risk of poor visual outcomes and surgery. The treatment, low concentration polihexanide (PHMB 0.08%), follows a novel and evidence-based protocol.
Researchers have developed a novel approach, REVeRT, to efficiently transport large genes using dual AAV vectors at the transcript level. This new method offers increased efficiency, fewer side effects, and greater flexibility compared to existing strategies.
A large data study suggests extending annual screens to 2 years for those at 'low risk' of diabetic eye disease could lead to critical delays in treatment and/or sight loss. The research, based on a diverse database, found that Black people are significantly more likely to develop sight-threatening diabetic eye disease.
Researchers developed a novel 'pseudo cell' formulation using self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases. The treatment demonstrated therapeutic benefits in both murine and nonhuman primate models, offering potential for improved patient compliance.
A team of researchers has created a 'proteomic clock' that can predict a healthy person's age based on their protein profile, revealing accelerated aging due to diseases. The study also detected proteins associated with Parkinson's disease in eye fluid, offering a potential pathway for earlier diagnoses.
A retrospective study found that research staff of the same race or ethnicity as patients increased consent rates by 65.1% compared to those of a different race or ethnicity. Employing diverse research teams can improve trust and engagement among potential study participants, according to researchers.
Stanford Medicine researchers developed a technique to measure ocular aging using artificial intelligence, predicting disease triggers and revealing new targets for therapies. The study found that certain proteins accelerate aging in each disease, potentially leading to personalized treatments.
A new UK study finds that people with eating disorders are 2.11 times more likely to report physical multimorbidity. Anxiety, insomnia, and perceived stress are key influencers in this relationship.
Mutations in the EMC1 gene are associated with familial exudative vitreoretinopathy (FEVR), a severe ocular condition. The discovery highlights the pivotal role of EMC1 in retinal blood vessel development via the Wnt signaling pathway.
A recent human study found that grape consumption improved key markers of eye health in older adults, including increased Macular Pigment Optical Density (MPOD) and reduced AGEs. Regular grape intake was also shown to increase plasma antioxidant capacity and total phenolic content.
Brazilian researchers screened 160 existing drugs and identified six compounds effective against Toxoplasma gondii. Almitrine, a COPD treatment, showed significant reduction in brain parasite load. Further studies are needed to repurpose these drugs for toxoplasmosis treatment.
Researchers analyzed UK data to identify patterns of illnesses in individuals leading up to a type 2 diabetes diagnosis. High blood pressure, respiratory tract infections, heart conditions, and asthma were commonly observed, suggesting earlier diagnosis may be possible.
A new compound developed at the University of Illinois Chicago potentially offers an alternative to injections for wet age-related macular degeneration, a leading cause of blindness. The drug targets End Binding-3 and has been shown to reverse damage and promote regenerative processes in animal models.
Researchers identified abnormal keratin expression patterns in senescent ocular surface cells, which may contribute to severe ocular surface diseases. Gene expression profiles showed substantial differences between senescent and non-senescent cells, highlighting their potential role in pathology.
A significant increase in the need for treatment of eye diseases is expected due to the growing elderly population. The number of patients requiring anti-VEGF medication is projected to rise by 50% over the next five years.
Researchers have identified a new mechanism of blindness caused by the lack of CERKL gene, leading to permanent retinal stress and cell death. This discovery opens the door to future treatments based on precision medicine.